New Strategies to Detect Cancers in Carriers of Mutations in RB1

Clinical trial NCT04164134 · COMPLETED

Trial details

NCT number: NCT04164134
Sponsor: Amsterdam UMC, location VUmc
Status: COMPLETED
Study type: OBSERVATIONAL

Retinoblastoma Secondary Primary Malignancies After Retinoblastoma

Start date: 2018-12-13
Primary completion: 2023-03-31
Enrollment: 378

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.